|
US 11,872,270 B2 |
|
| A*03 restricted peptides for use in immunotherapy against cancers and related methods |
| Colette Song, Ostfildern (DE); Linus Backert, Tuebingen (DE); Heiko Schuster, Tuebingen (DE); Daniel Johannes Kowalewski, Kirchentellinsfurt (DE); Oliver Schoor, Tuebingen (DE); Jens Fritsche, Dusslingen (DE); Toni Weinschenk, Aichwald (DE); and Harpreet Singh, Munich (DE) |
| Assigned to IMMATICS BIOTECHNOLOGIES GMBH, Tuebingen (DE) |
| Filed by Immatics Biotechnologies GmbH, Tuebingen (DE) |
| Filed on Jan. 14, 2021, as Appl. No. 17/149,397. |
| Application 17/149,397 is a continuation of application No. 16/446,384, filed on Jun. 19, 2019, granted, now 10,946,081. |
| Application 16/446,384 is a continuation of application No. 16/030,725, filed on Jul. 9, 2018, granted, now 10,925,947. |
| Claims priority of provisional application 62/692,348, filed on Jun. 29, 2018. |
| Claims priority of application No. 102018115865.3 (DE), filed on Jun. 29, 2018; and application No. 102018116584.6 (DE), filed on Jul. 9, 2018. |
| Prior Publication US 2021/0128708 A1, May 6, 2021 |
| This patent is subject to a terminal disclaimer. |
| Int. Cl. C07K 16/30 (2006.01); A61K 39/00 (2006.01); A61P 35/00 (2006.01); C07K 7/06 (2006.01); C07K 16/28 (2006.01) |